SpringerLink
Log in

Endovascular Management of Malignant Inferior Vena Cava Syndromes

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

Malignant obstructions of the inferior vena cava (IVC) are a common cause of the IVC syndrome. As reports on interventional treatment of malignant inferior caval obstructions are very sparse, the purpose of this study was to retrospectively assess the outcome of endovascular treatment of symptomatic, malignant IVC syndromes.

Materials and Methods

Between 2000 and 2015, 19 patients (six women; mean age 59 years ± 14) received endovascular treatment of malignant IVC obstruction/occlusion. Patients’ demographics as well as interventional and clinical outcome data were collected.

Results

All 19 patients underwent stenting of the IVC. Technical success was 100%. Clinical success was 79% (15/19). Three patients (16%) required early re-intervention (days 1–8) due to stent compression. Three patients (16%) with initially good post-interventional results required late repeated intervention due to tumor progression, and repeated intervention could alleviate symptoms in all cases. Best results were achieved when choosing a stent diameter between 16 and 20 mm and a stent length approximately 15–20 mm longer than the lesion length. Too large stent diameters (>28 mm) can lead to stent compression, too small stent diameters (<14 mm) can lead to stent migration, and too short stent lengths can lead to a reoccurrence of symptoms with obstruction of a non-treated segment.

Conclusion

Endovascular treatment of malignant IVC syndromes is a safe and effective approach enabling immediate relief of inferior inflow congestions. Recurrent venous obstruction is common but can be avoided when stent diameter and stent length are adapted to the degree of IVC compression as well as expected progression of the underlying malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Entwisle KG, Watkinson AF, Hibbert J, Adam A. The use of the Wallstent endovascular prosthesis in the treatment of malignant inferior vena cava obstruction. Clin Radiol. 1995;50(5):310–3.

    Article  CAS  PubMed  Google Scholar 

  2. Oudkerk M, Heystraten FM, Stoter G. Stenting in malignant vena caval obstruction. Cancer. 1993;71(1):142–6.

    Article  CAS  PubMed  Google Scholar 

  3. Harris RD. The etiology of inferior vena caval obstruction and compression. CRC Crit Rev Clin Radiol Nucl Med. 1976;8(1):57–86.

    CAS  PubMed  Google Scholar 

  4. Son HS, Sun K, Jung JS, Park SM, Lee SH, Kim KT. Intimal cardiac sarcoma in a pregnant woman. Asian Cardiovasc Thorac Ann. 2007;15(1):66–8.

    Article  PubMed  Google Scholar 

  5. Patel SA. The inferior vena cava (IVC) syndrome as the initial manifestation of newly diagnosed gastric adenocarcinoma: a case report. J Med Case Rep. 2015;9:204.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hartley JW, Awrich AE, Wong J, Stevens K, Fletcher WS. Diagnosis and treatment of the inferior vena cava syndrome in advanced malignant disease. Am J Surg. 1986;152(1):70–4.

    Article  CAS  PubMed  Google Scholar 

  7. Bower TC, Nagorney DM, Cherry KJ Jr, et al. Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg. 2000;31(2):270–81.

    Article  CAS  PubMed  Google Scholar 

  8. Furui S, Sawada S, Kuramoto K, et al. Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology. 1995;195(1):147–52.

    Article  CAS  PubMed  Google Scholar 

  9. Razavi MK, Hansch EC, Kee ST, Sze DY, Semba CP, Dake MD. Chronically occluded inferior venae cavae: endovascular treatment. Radiology. 2000;214(1):133–8.

    Article  CAS  PubMed  Google Scholar 

  10. Stambo GW, Leto J, Van Epps K, Woeste T, George C. Endovascular treatment of intrahepatic inferior vena cava obstruction from malignant hepatocellular tumor thrombus utilizing Luminexx self-expanding nitinol stents. South Med J. 2006;99(10):1148–9.

    Article  PubMed  Google Scholar 

  11. Maleux G, Vertenten B, Laenen A, et al. Palliative endovascular treatment of cancer-related iliocaval obstructive disease: technical and clinical outcomes. Acta Radiol. 2015;57:451–6.

    Article  PubMed  Google Scholar 

  12. Gloviczki P, Pairolero PC, Toomey BJ, et al. Reconstruction of large veins for nonmalignant venous occlusive disease. J Vasc Surg. 1992;16(5):750–61.

    Article  CAS  PubMed  Google Scholar 

  13. Srinivas BC, Dattatreya PV, Srinivasa KH, Prabhavathi, Manjunath CN. Inferior vena cava obstruction: long-term results of endovascular management. Indian Heart J. 2012;64(2):162–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Furui S, Sawada S, Irie T, et al. Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. Radiology. 1990;176(3):665–70.

    Article  CAS  PubMed  Google Scholar 

  15. Irving JD, Dondelinger RF, Reidy JF, et al. Gianturco self-expanding stents: clinical experience in the vena cava and large veins. Cardiovasc Intervent Radiol. 1992;15(5):328–33.

    Article  CAS  PubMed  Google Scholar 

  16. Charnsangavej C, Carrasco CH, Wallace S, et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology. 1986;161(2):295–8.

    Article  CAS  PubMed  Google Scholar 

  17. Wilhelm K, Schild H, Bruch E, et al. Stent implantation as a palliative therapeutic measure in tumor-induced stenoses of the large veins of the body. Rofo. 1995;162(6):514–20.

    Article  CAS  PubMed  Google Scholar 

  18. Devcic Z, Techasith T, Banerjee A, Rosenberg JK, Sze DY. Technical and Anatomic Factors Influencing the Success of Inferior Vena Caval Stent Placement for Malignant Obstruction. J Vasc Interv Radiol. 2016;27(9):1350-60.e1.

    Article  Google Scholar 

  19. Neglen P, Raju S. Balloon dilation and stenting of chronic iliac vein obstruction: technical aspects and early clinical outcome. J Endovasc Ther. 2000;7(2):79–91.

    Article  CAS  PubMed  Google Scholar 

  20. Wallace MJ. Transatrial stent placement for treatment of inferior vena cava obstruction secondary to extension of intracardiac tumor thrombus from hepatocellular carcinoma. J Vasc Interv Radiol. 2003;14(10):1339–43.

    Article  PubMed  Google Scholar 

  21. Zamora CA, Sugimoto K, Mori T, et al. Prophylactic stenting of the inferior vena cava before transcatheter embolization of renal cell carcinomas: an alternative to filter placement. J Endovasc Ther. 2004;11(1):84–8.

    Article  PubMed  Google Scholar 

  22. Sehgal M, Brown DB, Picus D. Aortoatrial fistula complicating transjugular intrahepatic portosystemic shunt by protrusion of a stent into the right atrium: radiologic/pathologic correlation. J Vasc Interv Radiol. 2002;13(4):409–12.

    Article  PubMed  Google Scholar 

  23. Tanigawa N, Sawada S, Mishima K, et al. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Comparison with conventional treatment. Acta Radiol. 1998;39(6):669–74.

    Article  CAS  PubMed  Google Scholar 

  24. mCho Y, Gwon DI, Ko GY, et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective? Korean J Radiol. 2014;15(1):87–94.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Bonn, Sigmund-Freud-Str.25, 53127, Bonn, Germany

    Daniel Kuetting, Daniel Thomas, Claus C. Pieper, Hans H. Schild & Carsten Meyer

  2. Department of Radiology, Johanniter Krankenhaus, Bonn, Germany

    Kai Wilhelm

Authors
  1. Daniel Kuetting
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kai Wilhelm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claus C. Pieper
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hans H. Schild
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carsten Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Kuetting.

Ethics declarations

Conflict of interest

None of the authors have any potential conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuetting, D., Thomas, D., Wilhelm, K. et al. Endovascular Management of Malignant Inferior Vena Cava Syndromes. Cardiovasc Intervent Radiol 40, 1873–1881 (2017). https://doi.org/10.1007/s00270-017-1740-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-017-1740-z

Keywords

Search

Navigation